[
    [
        {
            "time": "",
            "original_text": "财政部出手！清查药企“带金销售”，剑指药价虚高，涉及多家上市公司",
            "features": {
                "keywords": [
                    "财政部",
                    "清查",
                    "带金销售",
                    "药价虚高",
                    "上市公司"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "财政部出手！清查药企“带金销售”，剑指药价虚高，涉及多家上市公司",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "国信证券 - 医药行业一周观察：关注财报季投资机会，第四批药品集采即将落地执行【行业研究】",
            "features": {
                "keywords": [
                    "国信证券",
                    "医药行业",
                    "财报季",
                    "投资机会",
                    "药品集采"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国信证券 - 医药行业一周观察：关注财报季投资机会，第四批药品集采即将落地执行【行业研究】",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "19家药企被处罚，4700亿龙头在列，更有全球医药巨头",
            "features": {
                "keywords": [
                    "药企",
                    "处罚",
                    "龙头",
                    "全球医药巨头"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "19家药企被处罚，4700亿龙头在列，更有全球医药巨头",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        }
    ]
]